media – Page 588 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Are You Doing A Good Job In Bed?

A lack of sleep has been linked to high blood pressure and other cardiovascular ailments, mental health conditions like depression and weight-related issues such as obesity and diabetes.

Source: msn
660
December 20, 2017

Blockchain Health Tech Company Launches with $3.5 Million Seed

Curisium, a new healthcare technology that builds blockchain-based contracting technology for payers, providers, and life sciences companies, officially launche with the announcement that it has secured $3.5 million in seed funding.

Source: hcanews
652
December 19, 2017

Market Views Sanofi seed funding Series

Artificial Intelligence Could Help in Breast Cancer Diagnosis

Researchers say AI procedure was successful in detecting the spread of breast cancer. It’s the latest artificial intelligence innovation in the medical world.

Source: healthline
650
December 19, 2017

Artificial Intelligence breast cancer Researches

Electric eel-inspired devices could power artificial human organs

A flexible and transparent power source inspired by the electric eel could be used to power electrical devices in the body, such as cardiac pacemakers, implantable sensors or even prosthetic organs. The prototype, described in Nature1 on 13 December, runs on a solution of salt and water, but researchers hope that future versions might get their energy from bodily fluids.

Source: nature
450
December 19, 2017

electrical devices Researches

US FDA Accepts Regulatory Submission for TAGRISSO (Osimertinib) in 1st-Line EGFR-Mutated Non-Small Cell Lung Cancer

AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for the use of TAGRISSO® (osimertinib), a third-generation, irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) with clinical activity against central nervous system (CNS) metastases, in the 1st-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have EGFR mutations (exon 19 deletions or exon 21 (L858R) substitution mutations). The FDA has granted TAGRISSO Priority Review status, and previously granted Breakthrough Therapy Designation for TAGRISSO in the 1st-line treatment of patients with metastatic EGFR mutation-positive (EGFRm) NSCLC.

Source: finance.yahoo
613
December 19, 2017

AstraZeneca CNS FDA New Approvals NSCLC TAGRISSO®

FDA Accepts Biologics License Application for Fremanezumab with Priority Review for Prevention of Migraine and Grants Fast Track Designation for Cluster Headache Development Program

Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the U.S. Food and Drug Administration (FDA) has accepted for review the company’s Biologics License Application (BLA) for fremanezumab, an anti-calcitonin gene-related peptide (anti-CGRP) monoclonal antibody for the preventive treatment of migraine. Additionally, the FDA has granted fast track designation for fremanezumab for the prevention of cluster headache.

Source: finance.yahoo
570
December 19, 2017

cluster headache FDA fremanezumab migraine New Approvals Teva

Novartis-backed resTORbio raises $40M for aging disease trials

Boston biotech resTORbio has pocketed another $40 million from a second-round financing that it hopes gives it enough cash to move its lead candidate for respiratory tract infections in elderly patients into phase 3.

Source: Fiercebiotech
620
December 19, 2017

financing immune system Market Views Novartis

No interventions proven to prevent late-life dementia

There is no proven intervention for preventing late-life dementia. Researchers from the Minnesota Evidence-based Practice Center (EPC) reviewed published research to determine if physical activity, prescription medications, over-the-counter vitamins and supplements, or cognitive training interventions could help to prevent dementia in patients who did not have it at the time of the studies. The vast majority of research showed that none of the interventions worked. Findings from four systematic evidence reviews are published in Annals of Internal Medicine.

Source: medicalxpress
414
December 19, 2017

late-life dementia Researches

WHEN YOUR ACTIVITY TRACKER BECOMES A PERSONAL MEDICAL DEVICE

FITBIT SPENT ITS first decade selling activity trackers. With its latest moves, the company is starting to look less like a gear maker selling pricey accessories to fitness buffs and more like a medical-device company, catering to hospitals, patients, and health insurers. The company’s business-to-business arm, called Health Solutions, is now addressing four health conditions—sleep disorders including sleep apnea, diabetes, cardiovascular health and mental health—for employers, health insurers, healthcare providers, and researchers.

Source: wired
564
December 18, 2017

activity tracker sleep disorders

ODS Medical’s Innovative Device Could Revolutionize Brain Cancer Surgery

The Montreal-based startup ODS Medical is developing a handheld surgical guidance tool to improve accuracy in cancer surgery. Based on a set of advanced optical techniques, such as Raman spectroscopy, intrinsic fluorescence and diffuse reflectance spectroscopy, together with sophisticated machine learning algorithms, their laser technology measure scattered light to provide more specific information about the molecular makeup of the targeted brain tissue.

Source: mindsofmalady
561
December 18, 2017

cancer surgery Company Insight tumor

Are You Doing A Good Job In Bed?

Blockchain Health Tech Company Launches with $3.5 Million Seed

Artificial Intelligence Could Help in Breast Cancer Diagnosis

Electric eel-inspired devices could power artificial human organs

US FDA Accepts Regulatory Submission for TAGRISSO (Osimertinib) in 1st-Line EGFR-Mutated Non-Small Cell Lung Cancer

FDA Accepts Biologics License Application for Fremanezumab with Priority Review for Prevention of Migraine and Grants Fast Track Designation for Cluster Headache Development Program

Novartis-backed resTORbio raises $40M for aging disease trials

No interventions proven to prevent late-life dementia

WHEN YOUR ACTIVITY TRACKER BECOMES A PERSONAL MEDICAL DEVICE

ODS Medical’s Innovative Device Could Revolutionize Brain Cancer Surgery

Trending Topics

Hot Tags

Subscribe

more

more

Customer Services

About Us

Buy on Drugdu.com

Sell on Drugdu.com

Blogroll

Free APP

Follow Us